Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 157


Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.

Mahadevan A, Sampson C, LaRosa S, Floyd SR, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM.

Radiat Oncol. 2015 Nov 26;10(1):245.


Computational Identification of MoRFs in Protein Sequences Using Hierarchical Application of Bayes Rule.

Malhis N, Wong ET, Nassar R, Gsponer J.

PLoS One. 2015 Oct 30;10(10):e0141603. doi: 10.1371/journal.pone.0141603. eCollection 2015.


Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.

Lok E, Swanson KD, Wong ET.

Expert Rev Med Devices. 2015 Nov;12(6):717-26. doi: 10.1586/17434440.2015.1086641. Epub 2015 Oct 29.


Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.

Lai G, Mahadevan A, Hackney D, Warnke PC, Nigim F, Kasper E, Wong ET, Carter BS, Chen CC.

AJNR Am J Neuroradiol. 2015 Oct 1. [Epub ahead of print]


Stereotactic radiosurgery for brain metastases from malignant melanoma.

Christ SM, Mahadevan A, Floyd SR, Lam FC, Chen CC, Wong ET, Kasper EM.

Surg Neurol Int. 2015 Aug 20;6(Suppl 12):S355-65. doi: 10.4103/2152-7806.163315. eCollection 2015.


Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.

Wong ET, Swanson KD.

Br J Cancer. 2015 Sep 8. doi: 10.1038/bjc.2015.320. [Epub ahead of print] No abstract available.


Computed modeling of alternating electric fields therapy for recurrent glioblastoma.

Lok E, Hua V, Wong ET.

Cancer Med. 2015 Aug 26. doi: 10.1002/cam4.519. [Epub ahead of print]


An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.

Wong ET, Lok E, Swanson KD.

Curr Treat Options Oncol. 2015 Aug;16(8):40. doi: 10.1007/s11864-015-0353-5.


Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Wong ET, Lok E, Gautam S, Swanson KD.

Br J Cancer. 2015 Jul 14;113(2):232-41. doi: 10.1038/bjc.2015.238. Epub 2015 Jun 30.


Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit.

Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD.

PLoS One. 2015 May 26;10(5):e0125269. doi: 10.1371/journal.pone.0125269. eCollection 2015.


A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.

Lee EQ, Kaley TJ, Duda DG, Schiff D, Lassman AB, Wong ET, Mikkelsen T, Purow BW, Muzikansky A, Ancukiewicz M, Huse JT, Ramkissoon S, Drappatz J, Norden AD, Beroukhim R, Weiss SE, Alexander BM, McCluskey CS, Gerard M, Smith KH, Jain RK, Batchelor TT, Ligon KL, Wen PY.

Clin Cancer Res. 2015 Aug 15;21(16):3610-8. doi: 10.1158/1078-0432.CCR-14-3220. Epub 2015 Apr 24.


Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

Rangachari D, Yamaguchi N, VanderLaan PA, Folch E, Mahadevan A, Floyd SR, Uhlmann EJ, Wong ET, Dahlberg SE, Huberman MS, Costa DB.

Lung Cancer. 2015 Apr;88(1):108-11. doi: 10.1016/j.lungcan.2015.01.020. Epub 2015 Feb 4.


A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.

Wang F, Remke M, Bhat K, Wong ET, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh TC, O'Rourke ST, Wu L, Li DW, Hawkins C, Kohane IS, Wu JM, Wu M, Taylor MD, Wu E.

Oncotarget. 2015 Feb 20;6(5):2709-24.


The Enhanced Workflow and Efficiency of the Wireless Local Area Network (WLAN)-Based Direct Digital Radiography (DDR) Portable Radiography.

Ngan TL, Wong ET, Ng KL, Jeor PK, Lo GG.

J Digit Imaging. 2015 Jun;28(3):302-8. doi: 10.1007/s10278-014-9764-2.


Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY.

Neurology. 2015 Jan 20;84(3):280-6. doi: 10.1212/WNL.0000000000001153. Epub 2014 Dec 19.


A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time.

Li YC, Rodewald LW, Hoppmann C, Wong ET, Lebreton S, Safar P, Patek M, Wang L, Wertman KF, Wahl GM.

Cell Rep. 2014 Dec 11;9(5):1946-58. doi: 10.1016/j.celrep.2014.10.058. Epub 2014 Nov 20.


A feature analysis of lower solubility proteins in three eukaryotic systems.

Albu RF, Chan GT, Zhu M, Wong ET, Taghizadeh F, Hu X, Mehran AE, Johnson JD, Gsponer J, Mayor T.

J Proteomics. 2015 Apr 6;118:21-38. doi: 10.1016/j.jprot.2014.10.011. Epub 2014 Oct 25.


Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.

Kanner AA, Wong ET, Villano JL, Ram Z; EF-11 Investigators.

Semin Oncol. 2014 Oct;41 Suppl 6:S25-34. doi: 10.1053/j.seminoncol.2014.09.008. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e56-66.


Response patterns of recurrent glioblastomas treated with tumor-treating fields.

Vymazal J, Wong ET.

Semin Oncol. 2014 Oct;41 Suppl 6:S14-24. doi: 10.1053/j.seminoncol.2014.09.009. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e44-55.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk